• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮酒和吸烟对胰腺导管腺癌死亡率的影响:一项包含 1783 例患者的回顾性队列研究。

Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patients.

机构信息

Department of Pancreatic and Gastric Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Department of Surgery, Yale School of Medicine, Yale Cancer Center, New Haven, CT, USA.

出版信息

Sci Rep. 2017 Aug 29;7(1):9572. doi: 10.1038/s41598-017-08794-1.

DOI:10.1038/s41598-017-08794-1
PMID:28851896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5574975/
Abstract

The effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma (PDAC) mortality are contradictory. Individuals who were diagnosed as PDAC and hospitalized at the China National Cancer Center between January 1999 and January 2016 were identified and included in the study. Ultimately, 1783 consecutive patients were included in the study. Patients were categorized as never, ex-drinkers/smokers or current drinkers/smokers. Hazard ratios (HRs) of all-cause mortality and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. Compared with never drinkers, the HRs were 1.25 for ever drinkers, 1.24 for current drinkers, and 1.33 for ex-drinkers (trend P = 0.031). Heavy drinking and smoking period of 30 or more years were positive prognostic factors for PDAC. For different smoking and alcohol drinking status, only subjects who are both current smokers and current drinkers (HR, 1.45; 95% CI, 1.03-2.05) were associated with reduced survival after PDAC compared to those who were never smokers and never drinkers. Patients who are alcohol drinkers and long-term smokers before diagnosis have a significantly higher risk of PDAC mortality. Compared to those who neither smoker nor drink, only patients who both smokers and drinkers were associated with reduced survival from PDAC.

摘要

饮酒和吸烟对胰腺导管腺癌(PDAC)死亡率的影响是矛盾的。本研究纳入了 1999 年 1 月至 2016 年 1 月期间在中国国家癌症中心诊断为 PDAC 并住院的患者。最终,共有 1783 例连续患者纳入研究。患者被分为从不、曾经、现在饮酒/吸烟者。使用 Cox 比例风险模型估计全因死亡率的风险比(HR)和 95%置信区间(CI)。与从不饮酒者相比,曾经饮酒者的 HR 为 1.25,现在饮酒者为 1.24,曾经饮酒者为 1.33(趋势 P=0.031)。大量饮酒和吸烟 30 年或以上是 PDAC 的阳性预后因素。对于不同的吸烟和饮酒状况,只有同时吸烟和饮酒的患者(HR,1.45;95%CI,1.03-2.05)与 PDAC 患者的生存时间缩短相关,与从不吸烟和从不饮酒的患者相比。在诊断前有饮酒和长期吸烟史的患者 PDAC 死亡率的风险显著增加。与既不吸烟也不饮酒的患者相比,只有同时吸烟和饮酒的患者与 PDAC 的生存时间缩短相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8a/5574975/db7f457a8ebd/41598_2017_8794_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8a/5574975/57f11cc8b7ee/41598_2017_8794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8a/5574975/837e45b0f217/41598_2017_8794_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8a/5574975/db7f457a8ebd/41598_2017_8794_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8a/5574975/57f11cc8b7ee/41598_2017_8794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8a/5574975/837e45b0f217/41598_2017_8794_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8a/5574975/db7f457a8ebd/41598_2017_8794_Fig3_HTML.jpg

相似文献

1
Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patients.饮酒和吸烟对胰腺导管腺癌死亡率的影响:一项包含 1783 例患者的回顾性队列研究。
Sci Rep. 2017 Aug 29;7(1):9572. doi: 10.1038/s41598-017-08794-1.
2
The joint impact of smoking plus alcohol drinking on treatment of pulmonary tuberculosis.吸烟加饮酒对肺结核治疗的联合影响。
Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):651-657. doi: 10.1007/s10096-019-03489-z. Epub 2019 Feb 15.
3
Body mass index does not affect the survival of pancreatic cancer patients.体重指数并不影响胰腺癌患者的生存。
World J Gastroenterol. 2017 Sep 14;23(34):6287-6293. doi: 10.3748/wjg.v23.i34.6287.
4
ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.ABO血型、吸烟状况、其他危险因素与胰腺导管腺癌的预后
Medicine (Baltimore). 2020 Apr;99(14):e19413. doi: 10.1097/MD.0000000000019413.
5
Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck.吸烟和饮酒行为对头颈部鳞状细胞癌患者治疗结果的影响。
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1062-9. doi: 10.1016/j.ijrobp.2008.09.021. Epub 2008 Nov 25.
6
Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.胰腺癌患者Charlson 年龄合并症指数和其他危险因素的预后影响。
Eur J Cancer Care (Engl). 2020 May;29(3):e13219. doi: 10.1111/ecc.13219. Epub 2020 Jan 6.
7
Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.二甲双胍的使用与胰腺癌患者的生存:一个警示教训。
J Clin Oncol. 2016 Jun 1;34(16):1898-904. doi: 10.1200/JCO.2015.63.3511. Epub 2016 Apr 11.
8
Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.慢性乙型肝炎感染是晚期胰腺导管腺癌进展的保护因素吗?一项大型多中心队列研究的分析。
Oncotarget. 2016 Dec 20;7(51):85603-85612. doi: 10.18632/oncotarget.13000.
9
The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma.吸烟和饮酒对非霍奇金淋巴瘤患者生存的影响。
Int J Cancer. 2008 Apr 1;122(7):1624-9. doi: 10.1002/ijc.23205.
10
Clinical characteristics of second primary pancreatic cancer.第二原发性胰腺癌的临床特征
PLoS One. 2017 Jun 26;12(6):e0179784. doi: 10.1371/journal.pone.0179784. eCollection 2017.

引用本文的文献

1
Long-Term Survival in Pancreatic Adenocarcinoma with Metachronous Hepatic Metastases Using Multimodality Treatment Including Pegylated Liposomal Irinotecan and Capecitabine: A Case Report.采用包括聚乙二醇化脂质体伊立替康和卡培他滨在内的多模式治疗方案治疗伴有异时性肝转移的胰腺腺癌的长期生存:一例报告
Case Rep Oncol. 2025 Jun 12;18(1):920-928. doi: 10.1159/000546328. eCollection 2025 Jan-Dec.
2
[The Value of Clinical Characteristics and Hematological Parameters for Prognostic Assessment of Pancreatic Cancer Patients Undergoing Radical Resection].[临床特征和血液学参数对接受根治性切除的胰腺癌患者预后评估的价值]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):708-716. doi: 10.12182/20240560604.
3

本文引用的文献

1
Early detection of sporadic pancreatic cancer: time for change.散发性胰腺癌的早期检测:变革之时。
Eur J Gastroenterol Hepatol. 2017 Aug;29(8):885-891. doi: 10.1097/MEG.0000000000000904.
2
Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017.1980年至2013年胰腺癌死亡率的全球趋势及2017年预测
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1452-1462.e4. doi: 10.1016/j.cgh.2016.05.034. Epub 2016 Jun 3.
3
Cancer statistics, 2016.癌症统计数据,2016 年。
Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study.
基于临床影像组学模型预测胰腺导管腺癌生存结局的研究:一项多中心回顾性研究
Diagnostics (Basel). 2024 Mar 28;14(7):712. doi: 10.3390/diagnostics14070712.
4
Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients-A Single Center Analysis of 2323 Patients within the Last Decade.吸烟、体重、糖尿病、高血压及肾功能不全对胰腺癌患者生存的影响——对过去十年内2323例患者的单中心分析
J Clin Med. 2023 May 25;12(11):3656. doi: 10.3390/jcm12113656.
5
Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma.PAR1 介导的凝血信号通路作为胰腺导管腺癌的治疗靶点。
Int J Mol Sci. 2021 May 12;22(10):5138. doi: 10.3390/ijms22105138.
6
Are Prediagnostic Biomarkers of Inflammation and an Empirically Based Proinflammatory Dietary Pattern Associated With Poorer Pancreatic Cancer Survival?炎症的诊断前生物标志物以及基于经验的促炎饮食模式与胰腺癌较差的生存率相关吗?
J Natl Cancer Inst. 2021 Sep 4;113(9):1123-1124. doi: 10.1093/jnci/djab043.
7
From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma.从恶性进展到治疗靶点:胰腺导管腺癌中间皮素的最新研究进展。
Int J Mol Sci. 2020 Jun 6;21(11):4067. doi: 10.3390/ijms21114067.
8
The Diverse Involvement of Cigarette Smoking in Pancreatic Cancer Development and Prognosis.吸烟在胰腺癌发生发展及预后中的多方面作用
Pancreas. 2020 May/Jun;49(5):612-620. doi: 10.1097/MPA.0000000000001550.
9
ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.ABO血型、吸烟状况、其他危险因素与胰腺导管腺癌的预后
Medicine (Baltimore). 2020 Apr;99(14):e19413. doi: 10.1097/MD.0000000000019413.
10
Groove pancreatitis: a challenging imaging diagnosis.沟部胰腺炎:一项具有挑战性的影像学诊断。
Gland Surg. 2019 Sep;8(Suppl 3):S178-S187. doi: 10.21037/gs.2019.04.06.
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
4
Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment.尼古丁通过增强胰腺癌微环境中的旁分泌HGF-MET信号通路降低生存率。
Clin Cancer Res. 2016 Apr 1;22(7):1787-99. doi: 10.1158/1078-0432.CCR-15-1256. Epub 2015 Dec 14.
5
Alcohol and cigarette smoke components activate human pancreatic stellate cells: implications for the progression of chronic pancreatitis.酒精和香烟烟雾成分激活人胰腺星状细胞:对慢性胰腺炎进展的影响。
Alcohol Clin Exp Res. 2015 Nov;39(11):2123-33. doi: 10.1111/acer.12882. Epub 2015 Oct 14.
6
Impact of Smoking on Pancreatic Cancer Patients Receiving Current Chemotherapy.吸烟对接受当前化疗的胰腺癌患者的影响。
Pancreas. 2015 Oct;44(7):1155-60. doi: 10.1097/MPA.0000000000000395.
7
European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?2015 年欧洲癌症死亡率预测:肺癌是否是欧盟女性中死亡率最高的癌症?
Ann Oncol. 2015 Apr;26(4):779-786. doi: 10.1093/annonc/mdv001. Epub 2015 Jan 26.
8
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
9
European cancer mortality predictions for the year 2014.2014 年欧洲癌症死亡率预测。
Ann Oncol. 2014 Aug;25(8):1650-6. doi: 10.1093/annonc/mdu138. Epub 2014 Apr 23.
10
Smoking and body mass index and survival in pancreatic cancer patients.吸烟与体重指数与胰腺癌患者生存状况的关系。
Pancreas. 2014 Jan;43(1):47-52. doi: 10.1097/MPA.0b013e3182a7c74b.